Lantz Financial LLC Abb Vie Inc. Transaction History

Lantz Financial LLC

$351 Million
Q3 2024

A detailed history of Lantz Financial LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Lantz Financial LLC holds 6,451 shares of ABBV stock, worth $1.13 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

6,451

Previous 6,303 2.35%

Holding current value

$1.13 Million

Previous $1.08 Million 17.76%

% of portfolio

0.36%

Previous 0.35%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$163.84 - $199.33 $24,248 - $29,500	148 Added 2.35%	6,451 $1.27 Million
Q2 2024 Jul 10, 2024	SELL	$154.79 - $180.76 $38,233 - $44,647	-247 Reduced 3.77%	6,303 $1.08 Million
Q1 2024 Apr 10, 2024	SELL	$159.82 - $182.1 $164,774 - $187,745	-1,031 Reduced 13.6%	6,550 $1.19 Million
Q4 2023 Jan 12, 2024	BUY	$137.6 - $154.97 $120,537 - $135,753	876 Added 13.06%	7,581 $1.17 Million
Q3 2023 Oct 20, 2023	BUY	$133.59 - $154.65 $1,736 - $2,010	13 Added 0.19%	6,705 $999,000
Q2 2023 Jul 12, 2023	BUY	$132.51 - $164.9 $5,300 - $6,596	40 Added 0.6%	6,692 $901,000
Q1 2023 Apr 10, 2023	BUY	$144.61 - $166.54 $371,213 - $427,508	2,567 Added 62.84%	6,652 $1.06 Million
Q4 2022 Jan 23, 2023	BUY	$138.31 - $165.87 $5,532 - $6,634	40 Added 0.99%	4,085 $0
Q3 2022 Oct 17, 2022	BUY	$134.21 - $153.93 $2,684 - $3,078	20 Added 0.5%	4,045 $543,000
Q2 2022 Jul 29, 2022	SELL	$137.62 - $174.96 $84,636 - $107,600	-615 Reduced 13.25%	4,025 $616,000
Q1 2022 May 05, 2022	SELL	$131.98 - $163.75 $39,989 - $49,616	-303 Reduced 6.13%	4,640 $752,000
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $35,344 - $44,720	329 Added 7.13%	4,943 $669,000
Q3 2021 Oct 14, 2021	SELL	$106.4 - $120.78 $4,149 - $4,710	-39 Reduced 0.84%	4,614 $498,000
Q2 2021 Jul 16, 2021	BUY	$105.21 - $117.21 $68,491 - $76,303	651 Added 16.27%	4,653 $524,000
Q1 2021 Apr 19, 2021	BUY	$102.3 - $112.62 $22,301 - $24,551	218 Added 5.76%	4,002 $433,000
Q4 2020 Jan 19, 2021	SELL	$80.49 - $108.67 $987,531 - $1.33 Million	-12,269 Reduced 76.43%	3,784 $405,000
Q3 2020 Oct 09, 2020	SELL	$85.91 - $100.83 $4,209 - $4,940	-49 Reduced 0.3%	16,053 $1.41 Million
Q2 2020 Jul 22, 2020	SELL	$73.37 - $98.18 $16,434 - $21,992	-224 Reduced 1.37%	16,102 $1.58 Million
Q1 2020 Apr 10, 2020	BUY	$64.5 - $97.79 $840,306 - $1.27 Million	13,028 Added 395.03%	16,326 $1.24 Million
Q4 2019 Jan 17, 2020	BUY	$72.13 - $90.25 $8,511 - $10,649	118 Added 3.71%	3,298 $292,000
Q3 2019 Oct 18, 2019	BUY	$62.98 - $75.72 $3,526 - $4,240	56 Added 1.79%	3,180 $229,000
Q2 2019 Jul 15, 2019	BUY	$65.7 - $83.98 $15,505 - $19,819	236 Added 8.17%	3,124 $232,000
Q1 2019 Apr 22, 2019	BUY	$77.14 - $90.79 $222,780 - $262,201	2,888 New	2,888 $233,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lantz Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lantz Financial LLC with notifications on news.

Account

Lantz Financial LLC Abb Vie Inc. Transaction History